These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10476941)

  • 1. Low-dose oral use of human interferon-alpha in cancer patients.
    Cummins MJ; Pruitt B
    J Interferon Cytokine Res; 1999 Aug; 19(8):937-41. PubMed ID: 10476941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
    Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
    Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
    Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach.
    Jatoi A
    J Support Oncol; 2006; 4(10):499-502. PubMed ID: 17136864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
    Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
    Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological options for advanced cancer patients with loss of appetite and weight.
    Behl D; Jatoi A
    Expert Opin Pharmacother; 2007 Jun; 8(8):1085-90. PubMed ID: 17516872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the treatment of cancer-associated anorexia and weight loss.
    Yavuzsen T; Davis MP; Walsh D; LeGrand S; Lagman R
    J Clin Oncol; 2005 Nov; 23(33):8500-11. PubMed ID: 16293879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
    Quimby JM; Lunn KF
    Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involuntary weight loss in patients with advanced cancer: treatment is of modest benefit.
    J Support Oncol; 2006 Feb; 4(2):92. PubMed ID: 16499134
    [No Abstract]   [Full Text] [Related]  

  • 13. Appetite and appetite stimulants.
    Shaw C
    Eur J Cancer Care (Engl); 1993; 2(3):121-4. PubMed ID: 10889628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group.
    Ship JA; Fox PC; Michalek JE; Cummins MJ; Richards AB
    J Interferon Cytokine Res; 1999 Aug; 19(8):943-51. PubMed ID: 10476942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus.
    Cummins JM; Hutcheson DP; Cummins MJ; Georgiades JA; Richards AB
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):193-7. PubMed ID: 8129561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.
    Nelson K; Walsh D; Deeter P; Sheehan F
    J Palliat Care; 1994; 10(1):14-8. PubMed ID: 8035251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia.
    Beal JE; Olson R; Lefkowitz L; Laubenstein L; Bellman P; Yangco B; Morales JO; Murphy R; Powderly W; Plasse TF; Mosdell KW; Shepard KV
    J Pain Symptom Manage; 1997 Jul; 14(1):7-14. PubMed ID: 9223837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On appetite and its loss.
    Jatoi A; Kumar S; Sloan JA; Nguyen PL
    J Clin Oncol; 2003 May; 21(9 Suppl):79s-81s. PubMed ID: 12743203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.